Zynerba Pharmaceuticals, Inc.
ZYNEDelisted Oct 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621443
Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zynerba Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zynerba Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Moch Kenneth I | Director | 0 | Oct 11, 2023 | 0 |
| Kisner Daniel L | Director | 0 | Oct 11, 2023 | 0 |
| Cooper Warren D | Director | 0 | Oct 11, 2023 | 0 |
| Anido Armando | Chairman & Chief Exec. Officer | 0Indirect | Oct 11, 2023 | 0 |
| Federici William J | Director | 0 | Oct 11, 2023 | 0 |
| Sebree Terri B | President | 0 | Oct 11, 2023 | 0 |
| Fickenscher James E | Chief Financial Officer | 0 | Oct 11, 2023 | 0 |
| Butler John P. | Director | 0 | Oct 11, 2023 | 0 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 0 | Oct 11, 2023 | 0 |
| Parker Albert P | Chief Legal Officer | 0 | Oct 11, 2023 | 0 |
| Stephenson Pamela | Director | 0 | Oct 11, 2023 | 0 |
| Jones Kenneth T | See Remarks | 0 | Oct 11, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Sebree Terri BPresident | SSale | −12.4K | $1.33 | −$16.5K | −2.0%596.2K after | |
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −6.41K | $1.33 | −$8.53K | −2.5%249.6K after | |
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Fickenscher James EChief Financial Officer | SSale | −9.00K | $1.33 | −$12.0K | −2.3%378.1K after | |
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Jones Kenneth TSee Remarks | SSale | −2.50K | $1.33 | −$3.33K | −2.8%85.5K after | |
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Anido ArmandoChairman & Chief Exec. Officer | SSale | −17.8K | $1.33 | −$23.7K | −1.9%936.7K after | |
| Jun 15, 2023 (view filing)4:30 PM ET | Jun 14 | 1 day | Stephenson PamelaDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Jun 15, 2023 (view filing)4:30 PM ET | Jun 14 | 1 day | Moch Kenneth IDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Jun 15, 2023 (view filing)4:29 PM ET | Jun 14 | 1 day | Kisner Daniel LDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Jun 15, 2023 (view filing)4:29 PM ET | Jun 14 | 1 day | Federici William JDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Jun 15, 2023 (view filing)4:28 PM ET | Jun 14 | 1 day | Butler John P.Director | SSale | −115 | $0.3481 | −$40.03 | −0.1%80.8K after | |
| Jun 15, 2023 (view filing)4:28 PM ET | Jun 14 | 1 day | Cooper Warren DDirector | SSale | −115 | $0.3481 | −$40.03 | −0.2%75.8K after | |
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | Parker Albert PChief Legal Officer | SSale | −3.17K | $0.54 | −$1.71K | −1.4%227.0K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Sebree Terri BPresident | SSale | −24.7K | $0.60 | −$14.8K | −6.7%343.2K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Fickenscher James EChief Financial Officer | SSale | −17.8K | $0.60 | −$10.7K | −10.3%154.7K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −12.7K | $0.60 | −$7.60K | −11.8%94.8K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Anido ArmandoChairman & Chief Exec. Officer | SSale | −35.5K | $0.60 | −$21.3K | −5.8%576.2K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Sebree Terri BPresident | SSale | −8.28K | $1.10 | −$9.11K | −2.2%367.9K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Rosenberger BrianVP, Commercial & Business Dev. | SSale | −4.29K | $1.10 | −$4.72K | −3.8%107.5K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Fickenscher James EChief Financial Officer | SSale | −6.01K | $1.10 | −$6.61K | −3.4%172.5K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Anido ArmandoChairman & CEO | SSale | −11.9K | $1.10 | −$13.1K | −1.9%611.7K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Kisner Daniel LDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Federici William JDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Stephenson PamelaDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Moch Kenneth IDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Cooper Warren DDirector | SSale | −40 | $1.01 | −$40.4 | −0.1%28.1K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Butler John P.Director | SSale | −53 | $1.01 | −$53.53 | −0.2%33.1K after |